🎁 A holiday package to celebrate the season! Click here and shop now!

TextRanch

The best way to perfect your writing.

Discover why 1,062,726 users count on TextRanch to get their English corrected!

1. Input your text below.
2. Get it corrected in a few minutes by our editors.
3. Improve your English!

One of our experts will correct your English.

Our experts

concomitant causes vs concomitant factors

Both 'concomitant causes' and 'concomitant factors' are correct and commonly used phrases in English. They are interchangeable and can be used to refer to multiple causes or factors that occur together or are associated with a particular situation.

Last updated: March 24, 2024 • 1031 views

concomitant causes

This phrase is correct and commonly used in English.

This phrase is used to refer to multiple causes that occur together or are associated with a particular situation.

Examples:

  • The disease was caused by a combination of concomitant causes.
  • The concomitant causes of the economic crisis were identified by the researchers.
  • Concomitant treatment of the cause of the anaemia should be instituted.
  • Skin rashes (2 - 31%) are mainly described in patients with other concomitant medications known to cause rash (antibiotics and/ or allopurinol).
  • Epidemiological studies have suggested that concomitant administration of ACE inhibitors and antidiabetic medicinal products (insulins, oral hypoglycaemic agents) may cause an increased blood glucose lowering effect with risk of hypoglycaemia.
  • Antidiabetics Epidemiological studies have suggested that concomitant administration of ACE inhibitors and antidiabetic medicinal products (insulins, oral hypoglycaemic agents) may cause an increased blood glucose lowering effect with risk of hypoglycaemia.
  • Epidemiological studies have suggested that concomitant administration of ACE inhibitors and antidiabetic medicines (insulins, oral hypoglycaemic agents) may cause an increased blood-glucose lowering effect with risk of hypoglycaemia.
  • Patients receiving CellCept should be monitored for neutropenia, which may be related to CellCept itself, concomitant medications, viral infections, or some combination of these causes.
  • Sapropterin should be used with caution in patients who are receiving concomitant levodopa, as combined treatment with sapropterin may cause increased excitability and irritability.
  • Patients receiving Myfenax should be monitored for neutropenia, which may be related to Myfenax itself, concomitant medicinal products, viral infections, or some combination of these causes.
  • Concomitant use of INTELENCE with efavirenz or nevirapine may cause a significant decrease in the plasma concentration of etravirine and loss of therapeutic effect of INTELENCE.
  • Antidiabetics Epidemiological studies have suggested that concomitant administration of ACE inhibitors and antidiabetic medicines (insulins, oral hypoglycemic agents) may cause an increased blood-glucose- lowering effect with risk of hypoglycemia.
  • Interactions with lipid-lowering medicinal products that can cause myopathy when given alone The risk of myopathy, including rhabdomyolysis, is increased during concomitant administration with fibrates and niacin (nicotinic acid) (>= 1 g/ day).
  • Antidiabetic agents Epidemiological studies have suggested that concomitant administration of ACE inhibitors and antidiabetic medicines (insulins, oral hypoglycaemic agents) may cause an increased blood-glucose lowering effect with risk of hypoglycaemia.
  • Patients receiving Mycophenolate mofetil Teva should be monitored for neutropenia, which may be related to Mycophenolate mofetil Teva itself, concomitant medicinal products, viral infections, or some combination of these causes.
  • The concomitant use of potent CYP3A4 inhibitors such as ritonavir with IONSYS may result in an increase in fentanyl plasma concentrations, which could increase or prolong both the therapeutic and adverse events, and may cause serious respiratory depression.

Alternatives:

  • associated causes
  • simultaneous causes
  • coexisting causes
  • correlated causes
  • interrelated causes

concomitant factors

This phrase is correct and commonly used in English.

This phrase is used to refer to multiple factors that occur together or are associated with a particular situation.

Examples:

  • The success of the project was influenced by several concomitant factors.
  • The concomitant factors affecting climate change were analyzed by the experts.
  • In some cases concomitant factors may have contributed to the development of these effects.
  • A dental examination with appropriate preventive dentistry should be considered prior to treatment with bisphosphonates in patients with concomitant risk factors (e. g. cancer, chemotherapy, corticosteroids, poor oral hygiene).
  • A dental examination with appropriate preventive dentistry should be considered prior to treatment with bisphosphonates in patients with concomitant risk factors (e. g. cancer, chemotherapy, radiotherapy, corticosteroids, poor oral hygiene).
  • 3 A dental examination with appropriate preventive dentistry should be considered prior to treatment with bisphosphonates in patients with concomitant risk factors (e. g. cancer, chemotherapy, radiotherapy, corticosteroids, poor oral hygiene).
  • A dental examination with appropriate preventive dentistry should be considered prior to treatment with bisphosphonates in patients with concomitant risk factors (e. g. cancer, chemotherapy, corticosteroids, poor oral hygiene).
  • A dental examination with appropriate preventive dentistry should be considered prior to treatment with bisphosphonates in patients with concomitant risk factors (e. g. cancer, chemotherapy, radiotherapy, corticosteroids, poor oral hygiene, periodontal disease).
  • Confounding factors have included pre-existing liver disease or concomitant hepatotoxic medications.
  • Confounding factors have included pre-existing liver disease or concomitant hepatotoxic medications (see section 4.4).
  • Many patients treated with Caelyx have baseline myelosuppression due to such factors as their pre-existing HIV disease or numerous concomitant or previous medications, or tumours involving bone marrow.
  • Patients receiving concomitant treatment with anti-coagulants (e. g. warfarin; acenocumarole) may be periodically monitored by complete blood counts (platelets), coagulation factors (PT/ INR), and physical examination.
  • In most cases, risk factors have been identified, such as pre-existing renal insufficiency, diabetes mellitus, hypovolaemia, being overweight, concomitant nephrotoxic medicinal products or age over 65.
  • In most cases, risk factors have been identified, such as pre-existing renal insufficiency, diabetes mellitus, hypovolemia, overweight, concomitant nephrotoxic medicinal products or age over 65.
  • Yet another positive factor is the improvement in public finances - and the concomitant reduction in the rate of inflation - and long-term price stability.
  • Osteonecrosis of the jaws has multiple documented risk factors including a diagnosis of cancer, concomitant therapies (e. g. chemotherapy, radiotherapy, corticosteroids) and co-morbid conditions (e. g. anaemia, coagulopathies, infection, pre-existing oral disease).
  • Risk factors for the development of hyperkalaemia include renal insufficiency, diabetes mellitus, and concomitant use of potassium-sparing diuretics (e.g., spironolactone, triamterene or amiloride), potassium supplements or potassium-containing salt substitutes.
  • There have been rare cases of torsades de pointes in patients taking voriconazole who had risk factors, such as history of cardiotoxic chemotherapy, cardiomyopathy, hypokalaemia and concomitant medications that may have been contributory.
  • Osteonecrosis of the jaw has multiple well documented risk factors including a diagnosis of cancer, concomitant therapies (e. g. chemotherapy, radiotherapy, corticosteroids) and co-morbid conditions (e. g. anaemia, coagulopathies, infection, pre- existing dental disease).
  • Confounding or contributing factors such as concomitant or prior chemotherapy, prior radiotherapy, pre-existing parenchymal lung disease, metastatic lung disease, or pulmonary infections were frequent.
  • The observed incidence of antibody positivity in an assay may be influenced by several factors including sample handling, concomitant medications and underlying disease, therefore, comparison of the incidence of antibodies to other products may be misleading.
  • FIRMAGON has not been studied in patients with a history of a corrected QT interval over 450 msec, in patients with a history of or risk factors for torsades de pointes and in patients receiving concomitant medicinal products that might prolong the QT interval.

Alternatives:

  • associated factors
  • simultaneous factors
  • coexisting factors
  • correlated factors
  • interrelated factors

Related Comparisons

What Our Customers Are Saying

Our customers love us! We have an average rating of 4.79 stars based on 283,125 votes.
Also check out our 2,100+ reviews on TrustPilot (4.9TextRanch on TrustPilot).

Why choose TextRanch?

Lowest prices
Up to 50% lower than other online editing sites.

Fastest Times
Our team of editors is working for you 24/7.

Qualified Editors
Native English experts for UK or US English.

Top Customer Service
We are here to help. Satisfaction guaranteed!

×

💝 TextRanch Holidays Offer! 💝️

25% special discount
Stock up on credits for the entire year!

Grab this offer now!